Effect of monoclonal antibodies on limited proteolysis of native glycoprotein gD of herpes simplex virus type 1.
about
Disulfide bond structure of glycoprotein D of herpes simplex virus types 1 and 2Monoclonal antibodies to distinct sites on herpes simplex virus (HSV) glycoprotein D block HSV binding to HVEMGlobal sensing of the antigenic structure of herpes simplex virus gD using high-throughput array-based SPR imaging.Monoclonal antibodies to human cytomegalovirus: three surface membrane proteins with unique immunological and electrophoretic properties specify cross-reactive determinants.Molecular epitope identification by limited proteolysis of an immobilized antigen-antibody complex and mass spectrometric peptide mapping.Highly immunogenic and protective recombinant vaccine candidate expressed in transgenic plants.Immune-complex mimics as a molecular platform for adjuvant-free vaccine delivery.Effect of antigen/antibody ratio on macrophage uptake, processing, and presentation to T cells of antigen complexed with polyclonal antibodies.Murine monoclonal antibody to a single protein neutralizes the infectivity of human cytomegalovirus.High-level expression and purification of secreted forms of herpes simplex virus type 1 glycoprotein gD synthesized by baculovirus-infected insect cells.Equine herpesvirus 1 glycoprotein D: mapping of the transcript and a neutralization epitope.Cysteine mutants of herpes simplex virus type 1 glycoprotein D exhibit temperature-sensitive properties in structure and function.Influence of peptide acylation, liposome incorporation, and synthetic immunomodulators on the immunogenicity of a 1-23 peptide of glycoprotein D of herpes simplex virus: implications for subunit vaccines.Identification of C3b-binding regions on herpes simplex virus type 2 glycoprotein CDeletions in herpes simplex virus glycoprotein D define nonessential and essential domains.Serologic type conversion of a herpes simplex virus type 1 (HSV-1) to an HSV-2 epitope caused by a single amino acid substitution in glycoprotein C.Fine mapping of antigenic site II of herpes simplex virus glycoprotein DInfluence of asparagine-linked oligosaccharides on antigenicity, processing, and cell surface expression of herpes simplex virus type 1 glycoprotein D.Synthetic glycoprotein D-related peptides protect mice against herpes simplex virus challengeMonoclonal antibodies define a domain on herpes simplex virus glycoprotein B involved in virus penetrationExpression of herpes simplex virus type 1 glycoprotein D deletion mutants in mammalian cellsThe contribution of cysteine residues to antigenicity and extent of processing of herpes simplex virus type 1 glycoprotein DAntigenic analysis of a major neutralization site of herpes simplex virus glycoprotein D, using deletion mutants and monoclonal antibody-resistant mutantsLocalization of discontinuous epitopes of herpes simplex virus glycoprotein D: use of a nondenaturing ("native" gel) system of polyacrylamide gel electrophoresis coupled with Western blottingLocalization of a type-specific antigenic site on herpes simplex virus type 2 glycoprotein D.Fine structure analysis of type-specific and type-common antigenic sites of herpes simplex virus glycoprotein DLocalization of epitopes of herpes simplex virus type 1 glycoprotein DPotent neutralizing activity associated with anti-glycoprotein D specificity among monoclonal antibodies selected for binding to herpes simplex virions.Synthesis and processing of glycoprotein D of herpes simplex virus types 1 and 2 in an in vitro system.Localization and synthesis of an antigenic determinant of herpes simplex virus glycoprotein D that stimulates the production of neutralizing antibody.Amino-terminal sequence of glycoprotein D of herpes simplex virus types 1 and 2Direct demonstration that the abundant 6-kilobase herpes simplex virus type 1 mRNA mapping between 0.23 and 0.27 map units encodes the major capsid protein VP5.Neutralizing monoclonal antibodies specific for herpes simplex virus glycoprotein D inhibit virus penetrationDetailed analysis of the portion of the herpes simplex virus type 1 genome encoding glycoprotein C.Antigenic variants of herpes simplex virus selected with glycoprotein-specific monoclonal antibodies.Glycopeptides of the type-common glycoprotein gD of herpes simplex virus types 1 and 2.Antigenic differences between mannoproteins of germ tubes and blastospores of Candida albicansProtein antigen-monoclonal antibody contact sites investigated by limited proteolysis of monoclonal antibody-bound antigen: protein "footprinting".Human T-lymphocyte response in vitro to synthetic peptides of herpes simplex virus glycoprotein D.Prophylactic Herpes Simplex Virus 2 (HSV-2) Vaccines Adjuvanted with Stable Emulsion and Toll-Like Receptor 9 Agonist Induce a Robust HSV-2-Specific Cell-Mediated Immune Response, Protect against Symptomatic Disease, and Reduce the Latent Viral Rese
P2860
Q27486188-60BAD8DA-84A1-4C87-B3D9-7B9399C3DD60Q33782593-18CA3059-B9A7-4FDE-8546-12296FF865A4Q33834821-1B88A2BA-3962-4380-9CA8-E1AC21ADE0FDQ33912328-6E1D4117-2AFB-4B82-83A8-823DD6602670Q33926611-5B7E2261-2AF4-4CF1-8603-36C2E3AF6B9BQ34033969-581C3EEB-9FBD-4817-BC4E-9FB14181CE44Q34700024-3C52CF27-B9BC-409B-BA26-BA4854A332FCQ36229742-EE6C6089-8628-4433-88E4-91754DC571BDQ36254484-C8C7185D-2DA3-4C94-A65B-62FB880AECDDQ36626607-6E3C20FB-A0F7-455C-A010-493AD1DBF98AQ36685075-407433FA-9728-4AE2-90EA-462C70A93F49Q36793428-8E99B636-A7EE-4553-B68A-3D5874E4A3B1Q36800778-482F877B-70FE-413F-84C3-068A7B021E8DQ36804841-36D0B262-FC71-4C9E-BE80-026251EE12C4Q36805631-C76AD140-6970-47CD-9BF7-895518840166Q36812908-A6AAE7C8-BA7B-4D92-8447-82651B9F8520Q36827612-3EDD0E84-0D29-4EF3-B126-75A3E84941DAQ36832178-3F7C3955-E6A7-4B54-A44E-0D70424B1D49Q36855019-56178AA5-2578-4D6B-A727-5785826F7FADQ36868421-006A90FA-E876-460C-9863-7B9C13E85C98Q36868575-1ABF2F47-676F-4EFB-9978-9A6A5B6023CCQ36868606-3DCE028B-A6D9-45DF-8484-1ABBA83E7A02Q36872389-F1F73927-EDF6-4D25-A11C-0424DB0A9AE2Q36883752-42B3DBC6-3B12-4B39-9EDF-3192542298ADQ36892777-CE52C531-5AAE-414B-B5DA-380EF355E87FQ36895541-E2751243-6436-4BC7-A539-17EC48439D37Q36898378-3392D2DD-1A98-461B-84A5-78E7FFE97E39Q36903456-6CACCF8D-4C0A-4A5F-BF35-2F78551F86FAQ36909711-107333E7-091C-4C4A-87E3-85E087F73017Q36910738-19D76733-7F86-4BF5-8430-159D841629B7Q36911259-F35438C6-068B-4334-B442-7A9908C641BAQ36911422-2EB45654-8C46-48A8-9EE0-EC9EE953B96EQ36919500-B6EA5E14-6561-470E-9B7B-1866E5EF8857Q36930169-C597C7B6-51BE-4836-B562-FD396FCFDDBBQ36930264-55D1589D-4ABE-4AD9-87A0-3BF34B0E4D6EQ36931969-FBE136C3-0E23-42C0-A416-06163AF117E5Q37017114-57E2D5EB-D26D-41BE-A86C-0C10A3D78A24Q37479144-BC98FB18-021B-423C-9F0D-2DFCA65A4A6FQ37688772-EA54DE13-2661-4C9F-87D7-DF4342BCACEDQ38947443-D0443EAC-7127-43EC-AC36-33966CF978CF
P2860
Effect of monoclonal antibodies on limited proteolysis of native glycoprotein gD of herpes simplex virus type 1.
description
1982 nî lūn-bûn
@nan
1982年の論文
@ja
1982年論文
@yue
1982年論文
@zh-hant
1982年論文
@zh-hk
1982年論文
@zh-mo
1982年論文
@zh-tw
1982年论文
@wuu
1982年论文
@zh
1982年论文
@zh-cn
name
Effect of monoclonal antibodie ...... f herpes simplex virus type 1.
@en
type
label
Effect of monoclonal antibodie ...... f herpes simplex virus type 1.
@en
prefLabel
Effect of monoclonal antibodie ...... f herpes simplex virus type 1.
@en
P2093
P2860
P1433
P1476
Effect of monoclonal antibodie ...... f herpes simplex virus type 1.
@en
P2093
P2860
P304
P407
P577
1982-02-01T00:00:00Z